Skip to main content

Articles

Page 31 of 33

  1. Epithelial ovarian cancer (EOC) remains the most lethal of all the gynaecological malignancies with drug resistance and recurrence remaining the major therapeutic barrier in the management of the disease. Alth...

    Authors: Chantel Samardzija, Michael Quinn, Jock K Findlay and Nuzhat Ahmed
    Citation: Journal of Ovarian Research 2012 5:37
  2. The purpose of the study was to determine the incidence of gene expression of Oct-4 and DAZL, which are typical markers for stem cells, in human granulosa cells during ovarian stimulation in women with normal ...

    Authors: Michail Varras, Theodora Griva, Vasileios Kalles, Christodoulos Akrivis and Nikolaos Paparisteidis
    Citation: Journal of Ovarian Research 2012 5:36
  3. G protein-coupled receptor 30 (GPR30) is a 7-transmembrane estrogen receptor that functions alongside traditional estrogen receptors to regulate the cellular responses to estrogen. Recent studies suggest that ...

    Authors: Satoe Fujiwara, Yoshito Terai, Hiroshi Kawaguchi, Masaaki Takai, Saha Yoo, Yoshimichi Tanaka, Tomohito Tanaka, Satoshi Tsunetoh, Hiroshi Sasaki, Masanori Kanemura, Akiko Tanabe, Yoshiki Yamashita and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2012 5:35
  4. Resistance to apoptosis is a major problem in ovarian cancer and correlates with poor prognosis. Osteoprotegerin (OPG) is a secreted factor in malignant ascites and acts as a decoy receptor for receptor activa...

    Authors: Denis Lane, Isabelle Matte, Claudine Rancourt and Alain Piché
    Citation: Journal of Ovarian Research 2012 5:34
  5. Follicle stimulating hormone (FSH) exerts action on both germline and somatic compartment in both ovary and testis although FSH receptors (FSHR) are localized only on the somatic cells namely granulosa cells o...

    Authors: Deepa Bhartiya, Kalpana Sriraman, Pranesh Gunjal and Harshada Modak
    Citation: Journal of Ovarian Research 2012 5:32
  6. The resistance of endometriotic tissue to progesterone can be explained by alterations in the distribution of progesterone receptor (PR) and estrogen receptor (ER) isoforms. The aims of this study were to exam...

    Authors: Atsushi Hayashi, Akiko Tanabe, Sachiko Kawabe, Mika Hayashi, Hiroko Yuguchi, Yoshiki Yamashita, Kiyoji Okuda and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2012 5:31
  7. Endometriosis has critical implications for women’s quality of life. However, an overview of the current knowledge of this issue is limited. The objective of this systematic review was to determine the extent ...

    Authors: Shuang-zheng Jia, Jin-hua Leng, Jing-hua Shi, Peng-ran Sun and Jing-he Lang
    Citation: Journal of Ovarian Research 2012 5:29
  8. This study sought to evaluate the outcome of fresh and vitrified-warmed cleavage-stage and blastocyst-stage embryo transfers in patients undergoing ART treatment within an ethnic Chinese population.

    Authors: Guo Qing Tong, Shan Ren Cao, Xun Wu, Jun Qiang Zhang, Ji Cui, Boon Chin Heng and Xiu Feng Ling
    Citation: Journal of Ovarian Research 2012 5:27
  9. The aim of this study was to elucidate the regulatory role of androgen in the follicular development of wild female ground squirrels. Immunohistochemical staining of FSHR, LHR, P450c17, P450arom, androgen rece...

    Authors: Xiaonan Li, Haolin Zhang, Xia Sheng, Ben Li, Jiao Zhou, Meiyu Xu, Qiang Weng, Gen Watanabe and Kazuyoshi Taya
    Citation: Journal of Ovarian Research 2012 5:26
  10. Cigarette smoke is associated with decreased female fertility, causing damage to ovarian function and disturbing follicle development. However, the effects of cigarette toxicants on ovarian function depend on ...

    Authors: Larissa LO Paixão, Rejane P Gaspar-Reis, Gabrielle PL Gonzalez, Aline S Santos, Aluana C Santana, Rachel MM Santos, Poli Mara Spritzer and Celly Cristina A Nascimento-Saba
    Citation: Journal of Ovarian Research 2012 5:25
  11. The global gene regulator Special AT-rich sequence-binding protein1 (SATB1) has been reported to reprogramme tumour cells into a more malignant phenotype and associate with poor clinical outcome in several can...

    Authors: Björn Nodin, Charlotta Hedner, Mathias Uhlén and Karin Jirström
    Citation: Journal of Ovarian Research 2012 5:24
  12. Anti-VEGF treatment has proven effective in recurrent ovarian cancer. However, the identification of the patients most likely to respond is still pending. It is well known that the angiogenesis is regulated by...

    Authors: Christine Vestergaard Madsen, Karina Dahl Steffensen, Dorte Aalund Olsen, Marianne Waldstrøm, Maja Smerdel, Parvin Adimi, Ivan Brandslund and Anders Jakobsen
    Citation: Journal of Ovarian Research 2012 5:23
  13. Autophagy is a lysosomal-driven catabolic process that contributes to preserve cell and tissue homeostases through the regular elimination of damaged, aged and redundant self-constituents. In normal cells, aut...

    Authors: Claudia Peracchio, Oscar Alabiso, Guido Valente and Ciro Isidoro
    Citation: Journal of Ovarian Research 2012 5:22
  14. Ovarian cancer is predominant of epithelial cell origin and often present at an advanced stage with poor prognosis. Most animal models of ovarian carcinoma yield thecal/granulose cell tumors, rather than adeno...

    Authors: Yiping Huang, Wei Jiang, Yisheng Wang, Yufang Zheng, Qing Cong and Congjian Xu
    Citation: Journal of Ovarian Research 2012 5:21
  15. The aim of this study was to assess the clinical value of preoperative blood levels of HE4 as a predictor of overall survival in patients with ovarian cancer and to validate previous data of HE4 and the ROMA a...

    Authors: Grigorios Kalapotharakos, Christine Asciutto, Emir Henic, Bertil Casslén and Christer Borgfeldt
    Citation: Journal of Ovarian Research 2012 5:20
  16. It is well known that somatotrophic/insulin signaling affects lifespan in experimental animals, and one of the signs of aging is progressive gonadal dysfunction.

    Authors: Sylwia Słuczanowska-Głąbowska, Maria Laszczyńska, Katarzyna Piotrowska, Wojciech Głąbowski, John J Kopchick, Andrzej Bartke, Magda Kucia and Mariusz Z Ratajczak
    Citation: Journal of Ovarian Research 2012 5:18
  17. The addition of bevacizumab to standard chemotherapy prolongs progression free survival in the first line treatment of epithelial ovarian cancer (EOC), but its cost/effectiveness is debated. We assessed the sa...

    Authors: Carlotta Defferrari, Sara Campora, Mauro D'Amico, Arnoldo Piccardo, Ennio Biscaldi, Daniela Rosselli, Ambra Pasa, Matteo Puntoni, Alberto Gozza, Alessandra Gennari, Silvia Zanardi, Rita Lionetto, Michela Bandelloni and Andrea DeCensi
    Citation: Journal of Ovarian Research 2012 5:17
  18. Differences in the incidences and types of DNA damage induced by antitumor agents for clear cell carcinoma (CCC) were determined in 2 ovarian CCC cell lines using γH2AX.

    Authors: Eriko Takatori, Tadahiro Shoji, Seisuke Kumagai, Takashi Sawai, Akira Kurose and Toru Sugiyama
    Citation: Journal of Ovarian Research 2012 5:16
  19. The polycystic ovary syndrome ( PCOS) affects approximately 6-10% of women of reproductive age and is characterized by chronic anovulation and hyperandrogenism. However, a comprehensive understanding of the mecha...

    Authors: Fang Wang, Bolan Yu, Wenjing Yang, Jianqiao Liu, Jiachun Lu and Xuefeng Xia
    Citation: Journal of Ovarian Research 2012 5:15
  20. Polycystic Ovary Syndrome (PCOS) is a multifactorial pathology that affects 10% of the women in reproductive age being the main cause of infertility due to menstrual dysfunction. Since 1980, it is known that P...

    Authors: Rosalbino Isabella and Emanuela Raffone
    Citation: Journal of Ovarian Research 2012 5:14

    The Expression of Concern to this article has been published in Journal of Ovarian Research 2018 11:98

    The Expression of Concern to this article has been published in Journal of Ovarian Research 2018 11:57

  21. New treatment strategies are emerging to target DNA damage response pathways in ovarian cancer. Our group has previously shown that the class I biased HDAC inhibitor romidepsin (FK228) induces DNA damage respo...

    Authors: Andrew J Wilson, Yi-Qiang Cheng and Dineo Khabele
    Citation: Journal of Ovarian Research 2012 5:12
  22. Serum CA125 is routinely used in the follow up of ovarian cancer. The objective of the present study was to evaluate the usefulness of CA125 in the detection of ovarian cancer recurrence.

    Authors: Elizabeth Varughese, Srinivas Kondalsamy-Chennakesavan and Andreas Obermair
    Citation: Journal of Ovarian Research 2012 5:11
  23. Struma ovarii is a rare form of ovarian neoplasm in a form of mature teratoma and is composed predominantly of thyroid tissue. In the literature review, there has only been 10 cases of this tumor, associated w...

    Authors: Nahid Mostaghel, Anahita Enzevaei, Khandan Zare and Masoome Fallahian
    Citation: Journal of Ovarian Research 2012 5:10
  24. Even though ovarian tumors are not generally considered estrogen-sensitive, estrogens may still have an impact on ovarian tumor progression. The recently identified trans-membrane estrogen receptor GPER is inv...

    Authors: Zuzana Kolkova, Vera Casslén, Emir Henic, Sara Ahmadi, Anna Ehinger, Karin Jirström and Bertil Casslén
    Citation: Journal of Ovarian Research 2012 5:9
  25. MicroRNAs (miRNAs) are a class of small non-coding RNAs which function in gene regulation with an important role in cell proliferation, maturation, and activity. The regulatory role of these small RNA molecule...

    Authors: Jason Baley and Julang Li
    Citation: Journal of Ovarian Research 2012 5:8
  26. A crucial step in the metastatic spread of ovarian cancer (OC) is the adhesion and implantation of tumor cells to the peritoneal mesothelium. In order to study this step in the cascade, we derived a pro-metast...

    Authors: Takafumi Watanabe, Toshihiro Hashimoto, Takashi Sugino, Shu Soeda, Hiroshi Nishiyama, Yutaka Morimura, Hidekazu Yamada, Steve Goodison and Keiya Fujimori
    Citation: Journal of Ovarian Research 2012 5:7
  27. The Dachshund homolog 2 (DACH2) gene has been implicated in development of the female genital tract in mouse models and premature ovarian failure syndrome, but to date, its expression in human normal and cancerou...

    Authors: Björn Nodin, Marie Fridberg, Mathias Uhlén and Karin Jirström
    Citation: Journal of Ovarian Research 2012 5:6
  28. Melatonin (N-acetyl-5-methoxytryptamine) is secreted during the dark hours at night by pineal gland, and it regulates a variety of important central and peripheral actions related to circadian rhythms and repr...

    Authors: Hiroshi Tamura, Akihisa Takasaki, Toshiaki Taketani, Manabu Tanabe, Fumie Kizuka, Lifa Lee, Isao Tamura, Ryo Maekawa, Hiromi Aasada, Yoshiaki Yamagata and Norihiro Sugino
    Citation: Journal of Ovarian Research 2012 5:5
  29. RNA-Seq allows a theoretically unbiased analysis of both genome-wide transcription levels and mutation status of a tumor. Using this technique we sought to identify novel candidate therapeutic targets expresse...

    Authors: Rebecca A Mosig, Li Lin, Emir Senturk, Hardik Shah, Fei Huang, Peter Schlosshauer, Samantha Cohen, Robert Fruscio, Sergio Marchini, Maurizio D'Incalci, Ravi Sachidanandam, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2012 5:4
  30. We sought to identify candidate serum biomarkers for the detection and surveillance of EOC. Based on RNA-Seq transcriptome analysis of patient-derived tumors, highly expressed secreted proteins were identified...

    Authors: Rebecca A Mosig, Mollie Lobl, Emir Senturk, Hardik Shah, Samantha Cohen, Eugene Chudin, Robert Fruscio, Sergio Marchini, Maurizio D'Incalci, Ravi Sachidanandam, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2012 5:3
  31. Malignant ovarian disease is characterised by high rates of mortality due to high rates of recurrent chemoresistant disease. Anecdotal evidence indicates this may be due to chemoresistant properties of cancer ...

    Authors: Michael F Gallagher, Cynthia CBB Heffron, Alexandros Laios, Sharon A O'Toole, Brendan Ffrench, Paul C Smyth, Richard J Flavin, Salah A Elbaruni, Cathy D Spillane, Cara M Martin, Orla M Sheils and John J O'Leary
    Citation: Journal of Ovarian Research 2012 5:2
  32. Some techniques of transvaginal ovarian drilling have been previously described. Nevertheless a monopolar transvaginal ovarian cauterization, that use the expertise and safety of transvaginal puncture for oocy...

    Authors: Anita M Pimentel, Danielle Kobayashi, Lucia M Kliemann, Renato Franjdlich, Edison Capp and Helena VE Corleta
    Citation: Journal of Ovarian Research 2012 5:1
  33. Resistance to current chemotherapeutic agents is a major cause of therapy failure in ovarian cancer patients, but the exact mechanisms leading to the development of drug resistance remain unclear.

    Authors: Cheryl A Sherman-Baust, Kevin G Becker, William H Wood III, Yongqing Zhang and Patrice J Morin
    Citation: Journal of Ovarian Research 2011 4:21
  34. Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of...

    Authors: Anna Felisiak-Golabek, Alina Rembiszewska, Iwona K Rzepecka, Lukasz Szafron, Radoslaw Madry, Magdalena Murawska, Tomasz Napiorkowski, Piotr Sobiczewski, Beata Osuch and Jolanta Kupryjanczyk
    Citation: Journal of Ovarian Research 2011 4:20
  35. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of childbearing age, and it seems better to consider it as an ovarian manifestation of metabolic syndrome. The aim of the current stu...

    Authors: Afshin Mohammadi, Mohammadreza Aghasi, Leila Jodeiry-farshbaf, Shaker Salary-Lac and Mohammad Ghasemi-rad
    Citation: Journal of Ovarian Research 2011 4:19
  36. Glutathione peroxidase 3 (GPX3) is a selenocysteine-containing antioxidant enzyme that reacts with hydrogen peroxide and soluble fatty acid hydroperoxides, thereby helping to maintain redox balance within cell...

    Authors: Deep Agnani, Olga Camacho-Vanegas, Catalina Camacho, Shashi Lele, Kunle Odunsi, Samantha Cohen, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2011 4:18
  37. Ovarian cancer is the leading cause of death from gynecologic cancer in women worldwide. According to the National Cancer Institute, ovarian cancer has the highest mortality rate among all the reproductive can...

    Authors: Smriti Kumar, Arooshi Kumar, Parag P Shah, Shesh N Rai, Siva K Panguluri and Sham S Kakar
    Citation: Journal of Ovarian Research 2011 4:17
  38. The HOX genes are a family of homeodomain-containing transcription factors that determine cellular identity during development. Here we review a number of recent studies showing that HOX genes are strongly expres...

    Authors: Zoë L Kelly, Agnieszka Michael, Simon Butler-Manuel, Hardev S Pandha and Richard GL Morgan
    Citation: Journal of Ovarian Research 2011 4:16
  39. Adnexal cancers are in fifth place among the tumors with the highest mortality in the female population. The aim of the present study was to evaluate the accuracy of Multi-detector computed tomography (MDCT) o...

    Authors: Fatemeh Gatreh-Samani, Mohammad Kazem Tarzamni, Elaheh Olad-Sahebmadarek, Ali Dastranj and Aimaz Afrough
    Citation: Journal of Ovarian Research 2011 4:15
  40. Ovarian cancer is sixth most common cancer among women and the leading cause of death in women with gynecological malignancies. Despite the great impact ovarian cancer has on women's health and its great impac...

    Authors: Marcela F Paes, Renata D Daltoé, Klesia P Madeira, Lucas CD Rezende, Gabriela M Sirtoli, Alice L Herlinger, Leticia S Souza, Luciana B Coitinho, Débora Silva, Murilo F Cerri, Ana Cristina N Chiaradia, Alex A Carvalho, Ian V Silva and Leticia BA Rangel
    Citation: Journal of Ovarian Research 2011 4:14
  41. The presence of oocytes in the ovarian surface epithelium has already been confirmed in the fetal ovaries. We report the presence of SSEA-4, SOX-2, VASA and ZP2-positive primitive oocyte-like cells in the adul...

    Authors: Irma Virant-Klun, Thomas Skutella, Branko Cvjeticanin, Martin Stimpfel and Jasna Sinkovec
    Citation: Journal of Ovarian Research 2011 4:13
  42. Study of the hen immune system led to seminal contributions to basic immunological principles. Recent studies of spontaneous ovarian cancer in the laying hen show strikingly similar tumor types and antigen exp...

    Authors: Yi Yu, Seby L Edassery, Animesh Barua, Jacques S Abramowicz, Janice M Bahr, Ingegerd Hellstrom and Judith L Luborsky
    Citation: Journal of Ovarian Research 2011 4:12
  43. Endometriosis Health Profile (EHP-5) is a valid instrument to measure health-related quality of life in endometriosis. This study was conducted to culturally adapt and validate the EHP-5 in Iran.

    Authors: Azita Goshtasebi, Maryam Nematollahzadeh, Fatemeh Zahra Hariri and Ali Montazeri
    Citation: Journal of Ovarian Research 2011 4:11
  44. Epithelial ovarian cancer (EOC) is the leading cause of gynecologic cancer death in the USA. Recurrence rates are high after front-line therapy and most patients eventually die from platinum (Pt) - resistant d...

    Authors: Clarisse S Muenyi, Vanessa A States, Joshua H Masters, Teresa W Fan, C William Helm and J Christopher States
    Citation: Journal of Ovarian Research 2011 4:9

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.